This whitepaper updates CRDSA’s 2022 systematic review of data contributor policies and data protection methodologies. This update includes information published by 35 biopharma sponsors. Highlights include:
- The review now covers 35 biopharma sponsors, a 20% increase from 2022.
- The consistency of dataset- and documentation-sharing policy commitments establish a reference benchmark for all data contributing organizations.
- Challenges remain in the areas of data transformation transparency and data protection methodology.
Operationalizing privacy is challenging, but there are clear steps you can take to devise an operational policy that supports your business goals. This infographic lays out the important decision points in a logical, step-wise flow.